PON1 and metabolic dysfunction-associated steatohepatitis: We did not observe any significant influence of this allele on serum PON1 concentrations (Figure 4B), nor did we find any significant differences in the frequency of rs662 polymorphism in patients with or without NASH (Figure 4C).